IL12 antibody (AA 23-329, AA 26-222)
Quick Overview for IL12 antibody (AA 23-329, AA 26-222) (ABIN2287576)
Target
See all IL12 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 23-329, AA 26-222
 - 
                                            
Cross-Reactivity
 - Dog (Canine)
 - 
                                            
Cross-Reactivity (Details)
 - Calculated cross reactivity: Ca
 - 
                                            
Characteristics
 - Interleukin 12 (IL-12)
 - 
                                            
Purification
 - Purified by immunoaffinity chromatography.
 - 
                                            
Endotoxin Level
 - Endotoxin: ≤0.1EU/ug (LAL)
 - 
                                            
Immunogen
 - CHO-derived recombinant canine interleukin 12 p40 (aa23-329) and p35 (aa 26-222), UniProt #'s Q28268 and Q28267, respectively.
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working conditions should be determined by the investigator.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Reconstitution
 - Reconstitute with 0.5 mL sterile PBS.
 - 
                                            
Buffer
 - Supplied as a lyophilized powder from PBS, 5 % trehalose.
 - 
                                            
Storage
 - -20 °C
 - 
                                            
Storage Comment
 - -20°C
 
 - 
                                            
 - 
    
- IL12 (Interleukin 12 (IL12))
 - 
                                            
Alternative Name
 - Interleukin 12
 - 
                                            
UniProt
 - Q28268, Q28267
 - 
                                            
Pathways
 - JAK-STAT Signaling, TLR Signaling, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation, Cancer Immune Checkpoints, Inflammasome
 
Target
 -